1 / 5

Hepatitis C Diagnosis and Treatment Market 2027

Hepatitis C is the inflammation of liver caused by infection by hepatitis C virus characterized by a host of symptoms such as yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches

tejas1903
Download Presentation

Hepatitis C Diagnosis and Treatment Market 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hepatitis C Diagnosis and Treatment Market Research Report – Global Forecast till 2027 P a g e | 1 Copyright © 2017 Market Research Future.

  2. Hepatitis C Diagnosis and Treatment Market Research Report – Global Forecast till 2027 1Summary: Hepatitis C is the inflammation of liver caused by infection by hepatitis C virus characterized by a host of symptoms such as yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay coloured stools etc. According to the World Health Organisation, hepatitis C affects between 130–150 million people globally every year claiming a toll of 700000 lives. Of those who recover about 15-20% develop liver cirrhosis or liver cancer. According to Centres for Disease Control & Prevention, in U.S., liver cancer incidence is increasing at a rapid rate (2.3 % per year overall from 2003 – 2012), second only to thyroid cancer. Moreover, the rate of deaths due to liver cancer is increasing faster than for any other type of cancer. Furthermore, Hepatitis B and C are major contributing factors to liver cancer. Key Players: Hoffmann-La Roche Ltd (Switzerland), BMS (U.S), Merck & Co., Inc (U.S), Vertex Pharmaceuticals Incorporated (U.S), Gilead sciences Inc (U.S.)., Abbvie Inc (U.S.), Johnson & Johnson (U.S.), Glaxosmithkline plc (U.K), Novartis AG (Switzerland), Bristol-Myers Squibb (U.S.) are some of the prominent players at the forefront of competition in the Global Hepatitis C Diagnosis and Treatment Market and are profiled in MRFR Analysis. P a g e | 2 Copyright © 2017 Market Research Future.

  3. Hepatitis C Diagnosis and Treatment Market Research Report – Global Forecast till 2027 2 Segmentation Analysis: The Global Hepatitis C Diagnosis and Treatment Market has been segmented into diagnosis, treatment, end-user, and region. Based on diagnosis, the global hepatitis C diagnosis and treatment market has been divided into liver function tests, liver biopsy, blood tests, and others. The global hepatitis C diagnosis and treatment market, by treatment, has been segmented into antiviral medications, immune-modulators, liver transplantation, and others. The global hepatitis C diagnosis and treatment market, by end-user, has been segmented into hospitals & clinics, diagnostic centers, and others. The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hepatitis C diagnosis and treatment market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European hepatitis C diagnosis and treatment market has been segmented into Western Europe and Eastern Europe. The market in Western Europe has further been classified into France, Germany, Spain, the UK, Italy, and the rest of Western Europe. The hepatitis C diagnosis and treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Middle East & Africa hepatitis C diagnosis and treatment market has been segmented into the Middle East and Africa. P a g e | 3 Copyright © 2017 Market Research Future.

  4. Hepatitis C Diagnosis and Treatment Market Research Report – Global Forecast till 2027 3 Regional Analysis: Depending on geographic region, Hepatitis C diagnosis & treatment market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally, Americas is the largest market for global Hepatitis C diagnosis and treatment with Europe in the second position. However, the developed regions market is stagnant and will continue to do so with Asia Pacific region particularly India and China rising fast. Asia pacific region is expected to be fastest growing region in hepatitis C diagnosis & treatment market. The African region is expected to be a laggard and will show at most a moderate rate of growth. P a g e | 4 Copyright © 2017 Market Research Future.

  5. Hepatitis C Diagnosis and Treatment Market Research Report – Global Forecast till 2027 P a g e | 5 Copyright © 2017 Market Research Future.

More Related